The Neu4 Antibody has been validated for multiple techniques:
Key Validation Data:
NEU4 expression is linked to glioblastoma stem cell (GSC) survival:
Silencing NEU4 in GSCs reduced stemness markers (NANOG, OCT-4, SOX-2, CD133) and impaired survival by inhibiting pro-survival pathways (AKT, SHH, Wnt/β-catenin) .
NEU4 inhibition decreased ganglioside GD3 synthesis and altered glycosylation patterns, shifting cells toward differentiation .
NEU4 exhibits broad activity across sialylated substrates, including lysosomal glycoconjugates, and interacts with phospholipid scramblase 1, suggesting roles in membrane remodeling .
WB Protocol: Use RIPA buffer for lysate preparation; reduce exposure time for high-abundance samples .
IHC Protocol: Optimize antigen retrieval based on tissue type .
While primarily a research tool, the Neu4 Antibody has facilitated discoveries in oncology:
Glioblastoma: NEU4 activity correlates with GSC resilience, highlighting its potential as a therapeutic target .
Glycobiology: Insights into NEU4’s role in glycosylation patterns inform studies on metabolic disorders and cancer progression .
Neu4 is a mammalian sialidase that catalyzes the removal of sialic acid residues from glycoproteins and glycolipids. It plays an important regulatory role in neurite formation through the desialylation of glycoproteins. In situ hybridization studies have demonstrated that Neu4 mRNA is present primarily in the hippocampus, a region rich in Neural Cell Adhesion Molecule (NCAM), with expression that decreases after birth . This temporal and spatial expression pattern suggests Neu4 has a developmentally regulated function in neuronal tissues. Understanding Neu4's role contributes significantly to our knowledge of neuronal differentiation mechanisms, as evidenced by experiments showing that during retinoic acid-induced differentiation, Neu4 expression is down-regulated in Neuro2a cells .
Mouse Neu4 exists in two distinct isoforms: Neu4a and Neu4b. The primary structural difference is that Neu4a contains an additional 23 amino acid residues at the N-terminus compared to Neu4b. Unlike human NEU4L, which contains a mitochondrial-targeting signal at its N-terminus, PSORT II server analysis predicts no targeting signals within the additional 23 amino acids of mouse Neu4a .
When expressed as C-terminal HA-tagged proteins, Neu4a appears as a 55.0-kDa protein while Neu4b appears as a 53.3-kDa protein, consistent with their predicted molecular masses. These structural differences correlate with significant functional distinctions - Neu4b shows remarkable sialidase activity toward GD3, whereas Neu4a shows only slight increases in activity relative to mock transfectants . This differential enzymatic activity suggests distinct physiological roles for these isoforms in neuronal development and function.
Neu4, particularly the Neu4b isoform, demonstrates broad substrate specificity that distinguishes it from other mammalian sialidases. In substrate specificity studies using cell homogenates, Neu4b acts on glycolipids and glycoproteins as well as 4MU-sialic acid (4-methylumbelliferyl sialic acid), similar to human NEU4 but contrasting with the more restricted specificities of Neu1 and Neu3 .
A distinctive feature of Neu4 is its ability to remove sialic acids from bovine submaxillary mucin. Furthermore, both Neu4 isoforms show activity toward substrates containing α-2,8-sialyl linkages, including colominic acids (α-2,8-sialic acid polymer) and PSA-NCAM . The relative efficiency toward these substrates differs between isoforms - when comparing activities toward colominic acids normalized to GD3 activity, Neu4a shows 6.7-fold higher relative activity than Neu4b . This unique substrate profile likely reflects specialized neuronal functions and contributes to Neu4's role in neurite formation.
For detecting Neu4 expression in tissue samples, multiple complementary approaches can be employed:
In situ hybridization has proven effective for localizing Neu4 mRNA in tissue sections. Research protocols have successfully used digoxigenin-labeled RNA probes generated from selected mouse Neu4 cDNA fragments (nucleotides 231-638 from the start codon) . These probes should be fragmented to approximately 150 bp in length by alkaline treatment before use and designed to recognize both Neu4a and Neu4b isoforms. Positive signals can be detected using immunoassay with anti-digoxigenin-alkaline phosphatase conjugates and NBT/X-phosphate as the substrate .
Quantitative PCR with isoform-specific primers allows sensitive and quantitative detection of Neu4 isoforms. Primers targeting total Neu4 and Neu4a specifically can be combined with calculations (subtracting Neu4a from total) to quantify Neu4b expression .
Immunoblotting with antibodies against Neu4 or epitope tags (in transfected systems) provides protein-level detection, though researchers should note that C-terminal tagging may reduce enzymatic activity by approximately 30-50% .
Functional activity assays using specific substrates like GD3 can indirectly measure Neu4 presence and activity in samples when combined with appropriate controls.
For specific and accurate detection of Neu4 isoforms using PCR, the following validated primer sets should be employed:
Total mouse Neu4 detection:
Mouse Neu4a specific detection:
For Neu4b expression quantification:
For comparison studies with other sialidases, primers for rat Neu3 have been validated:
Sense: 5′-TGTCTACCTGGTGTTCAGACGA-3′ (nucleotides 159-180)
Antisense: 5′-GGAAAGCAGAGAAACCAGCATG-3′ (nucleotides 551-572)
These primer sets enable quantitative analysis of Neu4 isoform expression patterns across different tissues, developmental stages, or experimental conditions. When designing studies, researchers should consider the developmental regulation of Neu4, as its expression in hippocampus decreases after birth .
Optimizing in situ hybridization for Neu4 detection in brain tissues requires careful consideration of several methodological aspects:
Probe design and generation:
Select a mouse Neu4 cDNA fragment (nucleotides 231-638 from the start codon) that can recognize both Neu4a and Neu4b isoforms
Clone the selected fragment into an appropriate vector (such as Bluescript) in the correct orientation
Generate sense (negative control) and antisense (detection) probes by linearizing plasmids with restriction enzymes (HindIII and XbaI) and transcribing with appropriate RNA polymerases (T3 and T7) in the presence of digoxigenin-labeled UTP
Fragment probes to approximately 150 bp in length by alkaline treatment to improve tissue penetration and reduce background
Tissue preparation and hybridization conditions:
Signal detection:
This approach has successfully demonstrated Neu4 mRNA primarily in the hippocampus, providing valuable spatial information about expression patterns that complement quantitative PCR data .
Neu4 plays a critical regulatory role in neurite formation, with experimental evidence demonstrating a complex relationship between its expression and neuronal differentiation:
Temporal expression pattern during differentiation:
During retinoic acid-induced differentiation of Neuro2a cells, Neu4 expression is down-regulated, suggesting a potential inhibitory role in neuronal differentiation . This temporal regulation implies that reduction of Neu4 may be necessary for proper neuronal maturation.
Gain and loss-of-function studies:
Experimental manipulation of Neu4 levels provides compelling evidence for its functional role - overexpression of Neu4 results in suppression of neurite formation, while knockdown of Neu4 accelerates neurite outgrowth . This bidirectional modulation strongly supports Neu4's active involvement in regulating neuronal morphology.
Potential molecular mechanisms:
Lectin blot analysis of Neu4-transfected cells revealed increased binding to Ricinus communis agglutinin (RCA) lectin for a ~95-kDa glycoprotein, which decreased with cell differentiation . This suggests this glycoprotein may be a key substrate through which Neu4 exerts its regulatory function on neurite formation. The desialylation of this or other glycoproteins likely modulates cell adhesion or signaling processes critical for neurite extension.
These findings indicate that precise regulation of Neu4 expression and activity is important for proper neuronal development, with its downregulation potentially required for normal neurite extension during differentiation.
Determining the subcellular localization of Neu4 isoforms has proven methodologically challenging, with experiments yielding complex and sometimes inconclusive results:
These challenges highlight the need for improved detection methods and careful experimental design when investigating Neu4 subcellular distribution, potentially including advanced imaging techniques and biochemical fractionation approaches.
Neu4 demonstrates distinctive substrate specificity with important implications for its biological functions:
Range of substrates:
Neu4b acts efficiently on multiple substrate classes including glycolipids (like GD3), glycoproteins, and synthetic substrates like 4MU-sialic acid (4-methylumbelliferyl sialic acid) . This broad substrate range is similar to human NEU4 but contrasts with other mammalian sialidases like Neu1 and Neu3, which show more restricted specificities.
Activity toward heavily glycosylated proteins:
Unlike some other sialidases, Neu4b efficiently removes sialic acids from bovine submaxillary mucin, a heavily glycosylated protein . This activity may be relevant to its function in modifying neuronal cell surface glycoproteins.
α-2,8-sialyl linkage hydrolysis:
Both Neu4 isoforms show activity toward substrates containing α-2,8-sialyl linkages, including colominic acids (α-2,8-sialic acid polymer) and PSA-NCAM (polysialylated neural cell adhesion molecule) . This activity is particularly significant given the importance of polysialylated NCAM in neural development and plasticity.
Isoform-specific differences:
While both isoforms act on similar substrates, their relative efficiencies differ significantly. Neu4b shows much higher activity toward GD3, while Neu4a demonstrates relatively higher efficiency toward colominic acids when normalized to GD3 activity (6.7-fold higher than Neu4b) .
This detailed substrate profile provides insights into potential physiological targets and functional mechanisms of Neu4 in neuronal development, particularly through modification of cell adhesion molecules involved in neurite formation.
When confronted with contradictory results in Neu4 functional studies, researchers should implement a systematic approach to reconcile discrepancies:
Standardize experimental systems:
Cell type variability: Different neural cell lines may express varying levels of Neu4 substrates or regulatory factors
Expression level considerations: Effects observed in overexpression studies may differ from knockdown experiments or physiological contexts
Tagging strategies: C-terminal tags have been shown to reduce Neu4 activity by 30-50%, potentially confounding functional assessments
Differentiation protocols: The timing and method of inducing neuronal differentiation may influence Neu4's effects
Account for isoform-specific effects:
Clearly distinguish between Neu4a and Neu4b in experiments, as these isoforms show different enzymatic activities (Neu4b shows remarkably higher activity toward GD3 than Neu4a)
Use isoform-specific primers and quantification methods to accurately assess expression patterns
Consider the possibility of isoform-specific functions in different cellular contexts
Consider developmental and contextual regulation:
Neu4 expression changes during development (decreasing after birth in hippocampus) and during differentiation (downregulated during retinoic acid-induced differentiation)
Time-course studies may reveal transient effects missed in endpoint analyses
The ~95-kDa glycoprotein showing altered RCA lectin binding in Neu4-transfected cells could be a key substrate mediating context-dependent effects
By systematically addressing these factors, researchers can better reconcile conflicting results and develop a more coherent understanding of Neu4's diverse functional roles in neuronal development.
Developing specific antibodies against Neu4 presents several technical challenges that researchers must address:
Isoform specificity considerations:
Mouse Neu4 exists in two isoforms (Neu4a and Neu4b) differing by only 23 amino acids at the N-terminus
Generating antibodies that can either distinguish between these isoforms or recognize both requires careful epitope selection and validation
The additional 23 amino acids in Neu4a provide a potential target for isoform-specific antibodies, but may present challenges in accessibility and immunogenicity
Cross-reactivity with other sialidases:
Sialidases share conserved catalytic domains that may lead to cross-reactivity
Epitope selection should target unique regions of Neu4 to avoid non-specific binding to Neu1, Neu2, or Neu3
Extensive validation against other sialidase family members is essential
Expression level and localization challenges:
Endogenous Neu4 expression may be relatively low and developmentally regulated (decreasing after birth in hippocampus)
The apparent complex subcellular localization of Neu4, potentially involving multiple membrane compartments, may affect epitope accessibility
Different applications (western blotting vs. immunofluorescence) may require antibodies targeting different epitopes
Validation strategy requirements:
Testing against overexpressed tagged Neu4 isoforms
Confirming specificity using Neu4 knockout or knockdown samples
Correlation with mRNA expression patterns detected by in situ hybridization
Co-localization studies to confirm expected subcellular distribution patterns
These challenges highlight the importance of rigorous validation and potentially the need for application-specific antibodies for comprehensive Neu4 research.
While not directly related to Neu4, the methodological challenges in detecting anti-Neu5Gc antibodies highlight important considerations for glycobiology research that may have relevance for Neu4 studies:
Standardization of detection methods:
Despite almost 50 years since Neu5Gc was identified as the main immunogenic component of the Hanganutziu-Deicher antigen, no standardized method for detection or quantification of anti-Neu5Gc antibodies has been developed . Similar standardization would benefit Neu4 research.
Epitope presentation considerations:
The polyclonal nature of anti-Neu5Gc antibody responses, which may recognize various underlying structures, demonstrates the importance of epitope context in glycobiology . For Neu4 studies, considering how sialic acid removal affects the complete glycan structure is essential.
Avoiding reagent contamination:
Mammalian serum frequently used in cell culture can alter sialic acid profiles on cell surfaces . For Neu4 functional studies, researchers should similarly consider how culture conditions might affect substrate availability and enzyme activity.
Appropriate blocking agents:
Studies on anti-Neu5Gc antibodies revealed that using proteins from mammals endogenously synthesizing Neu5Gc (like BSA) versus those lacking it (like ovalbumin) significantly impacts detection rates . For Neu4 immunological studies, careful selection of blocking agents is similarly critical.
Matched controls:
Studies using matched pairs of target and control epitopes (differing only by a single hydroxyl group) showed higher detection rates than those without such controls . For Neu4 activity assays, appropriate substrate controls are equally important for accurate interpretation.
These methodological insights from Neu5Gc research provide valuable guidance for developing robust and reproducible approaches in Neu4 studies, particularly when investigating its substrate specificity and functional effects.